You are invited to join us at the Virtual ISPOR Congress May 17-20, 2021.
At ISPOR, we will share examples of how we work with our sponsors to demonstrate value for market access.
PCN38: A Literature Review Of Recurrent Or Metastatic Cervical Cancer Disease Burden, Treatment Outcomes, And Unmet Needs
Mark Bernauer, Omer Zaidi
PCN62: Real-World Costs of FRONT-LINE Treatment for Peripheral T-Cell Lymphoma in France, Germany, and the United Kingdom
Ruchit Shah, Shelby Corman
PCN192: Psychometric Validation of the EORTC QLQ-HCC18 in Patients with Previously Treated Unresectable Hepatocellular Carcinoma
Daniel Serrano, Lauren Podger
PMSS7: Adverse Event-Related Costs Associated with Abatacept and Upadacitinib for Moderate-to-Severe Rheumatoid Arthritis
Ning Ning, Dipen Patel
We welcome you to schedule some time to connect with one of our experts Shelby Corman, Andrew Revel or Philip Drew to discuss your market access, HEOR and real-world evidence needs.